The European Union drug agency has approved Moderna’s coronavirus vaccine candidate and provided Block with a second vaccine for use in the fight against the pandemic.
The European Medicines Agency’s Human Medicines Commission approval recommendation comes amid strong criticism that vaccine deployment programs are being implemented at a slow pace in an area of approximately 450 million people.
The EMA approved the Covid-19 vaccine developed by Pfizer and BioNTech before Christmas and shortly thereafter launched it to block citizens in 27 countries. Both vaccines require people to be given two jabs.
Emer Cooke, Executive Director of EMA, said: “This vaccine provides another tool for overcoming current emergencies.
“Only less than a year after the pandemic was declared by WHO, the recommendation of this second positive vaccine is a testament to the efforts and commitment of all involved.”
European Commission Chairman Ursula von der Leyen welcomed the news of the approval of the modern vaccine and said in a tweet: “Currently, we are working hard to approve it and make it available in the EU.”
The Moderna vaccine is easier to handle than the Pfizer / BioNTech vaccine because it does not need to be stored at an ultra-freezing temperature of -70 ° C and has already been approved in the United States, Canada and Israel.
German Health Minister Jens Spahn said he hopes the Modana vaccine will be rolled out to EU countries by next week. He was one of several EU leaders who were previously critical of the slow pace of EMA. As a result, authorities have advanced the timing of their Pfizer vaccine decision by a week.
Spahn told reporters in Berlin that Germany would receive 2 million doses in the first quarter and 50 million doses throughout 2021.
“The problem is the lack of production capacity due to global demand,” he said.
Austrian Prime Minister Sebastian Kurz tweeted that Moderna’s jab approval was “another important step in the fight against the pandemic.” This means that more vaccines are available in the EU and we can fight pandemics faster. “
Modana said on Monday that it has increased its estimate of global vaccine production this year from 500 million to 600 million, “investing and staff to increase the potential 1 billion doses in 2021. We continue to add, “he added.
Mr Cook emphasized that EU authorities “carefully monitor data on vaccine safety and efficacy to ensure continued protection of EU citizens.”
“Our work is always guided by scientific evidence and our commitment to protecting the health of EU citizens,” he added.
EU-approved Moderna Covid vaccine
Source link EU-approved Moderna Covid vaccine